Selective adherence of stent-graft coverings

US9492269B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9492269-B2
Application numberUS-201414310527-A
CountryUS
Kind codeB2
Filing dateJun 20, 2014
Priority dateSep 30, 1998
Publication dateNov 15, 2016
Grant dateNov 15, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An endoluminal prosthesis including a radially expandable support member having interior and exterior surfaces and a wall with openings, a first covering member including a biocompatible polymer material at least partially positioned against the interior surface, and a second covering member including a biocompatible polymer material at least partially positioned against the exterior surface. The first covering member attaches to the second covering member at predetermined bonding locations within less than all of the openings thereby leaving unbonded regions.

First claim

Opening claim text (preview).

What is claimed is: 1. An endoluminal prosthesis comprising: a radially expandable support member comprising interior and exterior surfaces and having a wall with openings, wherein the support member has two end portions and a middle portion arranged along a longitudinal axis; a first covering member comprising a biocompatible polymer material at least partially positioned against the interior surface; and a second covering member comprising a biocompatible polymer material at least partially positioned against the exterior surface wherein the second covering member covers all of the openings in at least the middle portion, wherein the first covering member attaches to the second covering member at predetermined bonding locations within less than all of the openings covered by the first and second covering members thereby leaving unbonded regions. 2. The endoluminal prosthesis of claim 1 wherein the support member and the first and second covering members have a tubular configuration. 3. The endoluminal prosthesis of claim 2 wherein first and second covering member lengths are equal to a support member length. 4. The endoluminal prosthesis of claim 3 wherein at least one unbonded region contains a drug. 5. The endoluminal prosthesis of claim 4 wherein the support member is composed of a self-expanding stent. 6. The endoluminal prosthesis of claim 5 wherein the biocompatible polymer material of the first or second covering member comprises expanded polytetrafluoroethylene. 7. The endoluminal prosthesis of claim 6 wherein the support member has a first diameter greater than a second diameter, wherein the first covering member attaches to the second covering member at the first diameter. 8. The endoluminal prosthesis of claim 2 wherein first and second covering member lengths are less than the support member length. 9. The endoluminal prosthesis of claim 1 wherein the predetermined bonding locations comprise an adhesive. 10. The endoluminal prosthesis of claim 9 wherein the adhesive is any one or any combination of polytetrafluoroethylene aqueous dispersions, polytetrafluoroethylene tapes, fluoroethylpolypropylenes (FEPs), tetrafluoroethylenes, polyurethanes, polyamides, polyimides or silicones. 11. The endoluminal prosthesis of claim 1 wherein the predetermined bonding locations comprise a thermoplastic polymer. 12. The endoluminal prosthesis of claim 11 wherein the thermoplastic polymer is any one or any combination of polyethylenes, polypropylenes, polyurethanes, or polyethylene terephthalates. 13. The endoluminal prosthesis of claim 1 wherein heat forms the bonding locations.

Assignees

Inventors

Classifications

  • Designing or manufacturing processes · CPC title

  • Medical equipment; Accessories therefor (bloodbags, medical bags B29L2031/7148; artificial eyes B29L2011/0008) · CPC title

  • by heating, with or without pressure · CPC title

  • using adhesives {, i.e. using supplementary joining material; solvent bonding} · CPC title

  • made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9492269B2 cover?
An endoluminal prosthesis including a radially expandable support member having interior and exterior surfaces and a wall with openings, a first covering member including a biocompatible polymer material at least partially positioned against the interior surface, and a second covering member including a biocompatible polymer material at least partially positioned against the exterior surface. T…
Who is the assignee on this patent?
Bard Peripheral Vascular Inc
What technology area does this patent fall under?
Primary CPC classification A61F2/07. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).